Terms: = Pancreatic cancer AND ARNT, HIF1BETA, 405, ENSG00000143437, P27540, HIF-1beta, HIF1B, TANGO
85 results:
1. Short-Term Outcomes Following Laparoscopic vs Open pancreaticoduodenectomy in Patients With pancreatic Ductal Adenocarcinoma: A Randomized Clinical Trial.
Wang M; Pan S; Qin T; Xu X; Huang X; Liu J; Chen X; Zhao W; Li J; Liu C; Li D; Liu J; Liu Y; Zhou B; Zhu F; Ji S; Cheng H; Li Z; Li J; Tang Y; Peng X; Yu G; Chen W; Ma H; Xiong Y; Meng L; Lu P; Zhang Z; Yu X; Zhang H; Qin R
JAMA Surg; 2023 Dec; 158(12):1245-1253. PubMed ID: 37878305
[TBL] [Abstract] [Full Text] [Related]
2. Prognoses of Patients Treated With Surgical Therapy Versus Continuation of Local-Plus-Systemic Therapy Following Successful Down-Staging of Intermediate-Advanced Hepatocellular Carcinoma: A Multicenter Real-World Study.
Liu J; Zhu X; Pan Y; Zhong J; Jin R; Zheng X; Zhang W; Hu K; Ma J; Shi X; Liu H; Yang X; Xu D; Ma C; Chen J; Wang D; Wang X; Li Z; Zhao L; Zhang L; Li T; Liu F; Tan G; Xing B; Zhao H; Zeng Y; Zhang S; Zhang L; Zhou L; Song T; Yang W; Liang X; Xiang B; Xu L; Sun H; Wang K
Oncologist; 2024 Apr; 29(4):e487-e497. PubMed ID: 37874924
[TBL] [Abstract] [Full Text] [Related]
3. Long-term cancer Survival Trends by Updated Summary Stage.
Forjaz G; Ries L; Devasia TP; Flynn G; Ruhl J; Mariotto AB
Cancer Epidemiol Biomarkers Prev; 2023 Nov; 32(11):1508-1517. PubMed ID: 37623930
[TBL] [Abstract] [Full Text] [Related]
4. Lorazepam Stimulates IL6 Production and Is Associated with Poor Survival Outcomes in pancreatic cancer.
Cornwell AC; Tisdale AA; Venkat S; Maraszek KE; Alahmari AA; George A; Attwood K; George M; Rempinski D; Franco-Barraza J; Seshadri M; Parker MD; Cortes Gomez E; Fountzilas C; Cukierman E; Steele NG; Feigin ME
Clin Cancer Res; 2023 Sep; 29(18):3793-3812. PubMed ID: 37587561
[TBL] [Abstract] [Full Text] [Related]
5. Genetic and epigenetic prognosticators of neuroendocrine tumours of the GI tract, liver, biliary tract and pancreas: A systematic review and meta-analysis.
Mestre-Alagarda C; Srirajaskanthan R; Zen Y; Giwa M; Howard M; Ooft ML
Histopathology; 2024 Jan; 84(2):255-265. PubMed ID: 37565289
[TBL] [Abstract] [Full Text] [Related]
6. Selective HIF2A Inhibitors in the Management of Clear Cell Renal cancer and Von Hippel-Lindau-Disease-Associated Tumors.
Suárez C; Vieito M; Valdivia A; González M; Carles J
Med Sci (Basel); 2023 Jun; 11(3):. PubMed ID: 37489462
[TBL] [Abstract] [Full Text] [Related]
7. Disruption of the Clock Component Bmal1 in Mice Promotes cancer Metastasis through the PAI-1-TGF-β-myoCAF-Dependent Mechanism.
Wu J; Jing X; Du Q; Sun X; Holgersson K; Gao J; He X; Hosaka K; Zhao C; Tao W; FitzGerald GA; Yang Y; Jensen LD; Cao Y
Adv Sci (Weinh); 2023 Aug; 10(24):e2301505. PubMed ID: 37330661
[TBL] [Abstract] [Full Text] [Related]
8. Global, Regional, and National Burden of pancreatic cancer, 1990-2019: Results from the Global Burden of Disease Study 2019.
Kan C; Liu N; Zhang K; Wu D; Liang Y; Cai W; Jing Q; Han F; Xing S; Sun X
Ann Glob Health; 2023; 89(1):33. PubMed ID: 37252335
[TBL] [Abstract] [Full Text] [Related]
9. The tango between cancer-Associated Fibroblasts (CAFs) and Immune Cells in Affecting Immunotherapy Efficacy in pancreatic cancer.
Stouten I; van Montfoort N; Hawinkels LJAC
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240052
[TBL] [Abstract] [Full Text] [Related]
10. Rheumatoid arthritis and risk of site-specific cancers: Mendelian randomization study in European and East Asian populations.
Yuan S; Chen J; Ruan X; Vithayathil M; Kar S; Li X; Mason AM; Burgess S; Larsson SC
Arthritis Res Ther; 2022 Dec; 24(1):270. PubMed ID: 36514134
[TBL] [Abstract] [Full Text] [Related]
11. Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor Hypoxia.
Toledo RA; Jimenez C; Armaiz-Pena G; Arenillas C; Capdevila J; Dahia PLM
Endocr Rev; 2023 Mar; 44(2):312-322. PubMed ID: 36301191
[TBL] [Abstract] [Full Text] [Related]
12. The hepatocellular carcinoma modified Gustave Roussy Immune score (HCC-GRIm score) as a novel prognostic score for patients treated with atezolizumab and bevacizumab: A multicenter retrospective analysis.
Hatanaka T; Naganuma A; Hiraoka A; Tada T; Hirooka M; Kariyama K; Tani J; Atsukawa M; Takaguchi K; Itobayashi E; Fukunishi S; Tsuji K; Ishikawa T; Tajiri K; Ochi H; Yasuda S; Toyoda H; Ogawa C; Nishimura T; Shimada N; Kawata K; Kosaka H; Kakizaki S; Tanaka T; Ohama H; Nouso K; Morishita A; Tsutsui A; Nagano T; Itokawa N; Okubo T; Arai T; Imai M; Koizumi Y; Nakamura S; Kaibori M; Iijima H; Hiasa Y; Kumada T;
Cancer Med; 2023 Feb; 12(4):4259-4269. PubMed ID: 36156452
[TBL] [Abstract] [Full Text] [Related]
13. Development and validation of the Massachusetts General Hospital/Memorial Sloan Kettering nomogram to predict overall survival of resected patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy.
Qiao G; Ilagan CH; Fernandez-Del Castillo C; Ferrone CR; Janseen QP; Balachandran VP; Sell NM; Drebin JA; Hank T; Kingham TP; D'Angelica MI; Jarnagin WR; Lillemoe KD; Wei AC; Qadan M
Surgery; 2022 Oct; 172(4):1228-1235. PubMed ID: 35931556
[TBL] [Abstract] [Full Text] [Related]
14. The outcome of intravenous and inhalation anesthesia after pancreatic cancer resection: a retrospective study.
Ren J; Wang J; Chen J; Ma Y; Yang Y; Wei M; Wang Y; Wang L
BMC Anesthesiol; 2022 May; 22(1):169. PubMed ID: 35637441
[TBL] [Abstract] [Full Text] [Related]
15. Belzutifan: A Narrative Drug Review.
Visweswaran V; Pavithran K
Curr Drug Res Rev; 2022; 14(2):88-95. PubMed ID: 35366789
[TBL] [Abstract] [Full Text] [Related]
16. Hepatocellular carcinoma as predominant cancer subgroup accounting for sex differences in post-hepatectomy liver failure, morbidity and mortality.
De la Cruz Ku G; Aizpuru M; Hackl H; Ubl DS; Habermann EB; Pery R; Driedger M; Assinger A; Nagorney DM; Cleary SP; Smoot RL; Starlinger P
HPB (Oxford); 2022 Sep; 24(9):1453-1463. PubMed ID: 35293321
[TBL] [Abstract] [Full Text] [Related]
17. Pre-operative radiomics model for prognostication in resectable pancreatic adenocarcinoma with external validation.
Healy GM; Salinas-Miranda E; Jain R; Dong X; Deniffel D; Borgida A; Hosni A; Ryan DT; Njeze N; McGuire A; Conlon KC; Dodd JD; Ryan ER; Grant RC; Gallinger S; Haider MA
Eur Radiol; 2022 Apr; 32(4):2492-2505. PubMed ID: 34757450
[TBL] [Abstract] [Full Text] [Related]
18. A simple risk score for detecting radiological occult metastasis in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma.
Sakaguchi T; Satoi S; Hashimoto D; Yamamoto T; Yamaki S; Hirooka S; Ishida M; Ikeura T; Inoue K; Sekimoto M
J Hepatobiliary Pancreat Sci; 2022 Feb; 29(2):262-270. PubMed ID: 34314568
[TBL] [Abstract] [Full Text] [Related]
19. Improving Gemcitabine Sensitivity in pancreatic cancer Cells by Restoring miRNA-217 Levels.
Panebianco C; Trivieri N; Villani A; Terracciano F; Latiano TP; Potenza A; Perri F; Binda E; Pazienza V
Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33925948
[TBL] [Abstract] [Full Text] [Related]
20. De Novo Colorectal and pancreatic cancer in Liver-Transplant Recipients: Identifying the Higher-Risk Populations.
Nasser-Ghodsi N; Mara K; Watt KD
Hepatology; 2021 Aug; 74(2):1003-1013. PubMed ID: 33544906
[TBL] [Abstract] [Full Text] [Related]
[Next]
